- Home
- EKSO vs TRIB Comparison
EKSO vs TRIB Comparison
Compare EKSO & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EKSO
- TRIB
- Stock Information
- Founded
- EKSO 2005
- TRIB 1992
- Country
- EKSO United States
- TRIB Ireland
- Employees
- EKSO N/A
- TRIB N/A
- Industry
- EKSO Medical/Dental Instruments
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- EKSO Health Care
- TRIB Health Care
- Exchange
- EKSO Nasdaq
- TRIB Nasdaq
- Market Cap
- EKSO 11.7M
- TRIB 12.5M
- IPO Year
- EKSO N/A
- TRIB N/A
- Fundamental
- Price
- EKSO $4.41
- TRIB $0.64
- Analyst Decision
- EKSO Strong Buy
- TRIB
- Analyst Count
- EKSO 2
- TRIB 0
- Target Price
- EKSO $37.50
- TRIB N/A
- AVG Volume (30 Days)
- EKSO 428.9K
- TRIB 68.1K
- Earning Date
- EKSO 07-28-2025
- TRIB 05-15-2025
- Dividend Yield
- EKSO N/A
- TRIB N/A
- EPS Growth
- EKSO N/A
- TRIB N/A
- EPS
- EKSO N/A
- TRIB N/A
- Revenue
- EKSO $17,544,000.00
- TRIB $61,555,000.00
- Revenue This Year
- EKSO $0.20
- TRIB $13.51
- Revenue Next Year
- EKSO $42.29
- TRIB $13.14
- P/E Ratio
- EKSO N/A
- TRIB N/A
- Revenue Growth
- EKSO N/A
- TRIB 8.31
- 52 Week Low
- EKSO $3.46
- TRIB $0.48
- 52 Week High
- EKSO $22.95
- TRIB $3.55
- Technical
- Relative Strength Index (RSI)
- EKSO 35.90
- TRIB 39.17
- Support Level
- EKSO $4.04
- TRIB $0.63
- Resistance Level
- EKSO $4.99
- TRIB $0.74
- Average True Range (ATR)
- EKSO 0.94
- TRIB 0.06
- MACD
- EKSO -0.04
- TRIB -0.02
- Stochastic Oscillator
- EKSO 15.04
- TRIB 1.92
About EKSO Ekso Bionics Holdings Inc.
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.